Table 1.
Remission | Crude | Adjusted* | ||||||
---|---|---|---|---|---|---|---|---|
Total | No | Yes | Hazard Ratio (95% CI) | P | Hazard Ratio (95% CI) | P | ||
Duration of uveitis prior to presentation | <6 Months | 834 (30%) | 593 (71%) | 241 (29%) | Ref | <0.001 | Ref | 0.02 |
6 Months to <2 Years | 620 (22%) | 464 (75%) | 156 (25%) | 0.81 (0.63, 1.05) | 0.78 (0.60, 1.03) | |||
2 to <5 Years | 512 (18%) | 414 (81%) | 98 (19%) | 0.58 (0.43, 0.78) | 0.61 (0.44, 0.83) | |||
5+ Years | 829 (30%) | 662 (80%) | 167 (20%) | 0.63 (0.48, 0.81) | 0.76 (0.58, 1.01) | |||
Bilateral | No | 379 (14%) | 283 (75%) | 96 (25%) | Ref | 0.008 | Ref | 0.02 |
Yes | 2416 (86%) | 1850 (77%) | 566 (23%) | 0.73 (0.58, 0.92) | 0.75 (0.59, 0.96) | |||
Prior cataract surgery | No | 2231 (80%) | 1698 (76%) | 533 (24%) | Ref | 0.03 | Ref | 0.002 |
Yes | 564 (20%) | 435 (77%) | 129 (23%) | 0.80 (0.65, 0.97) | 0.70 (0.56, 0.88) | |||
Any glaucoma surgery | No | 2627 (94%) | 1995 (76%) | 632 (24%) | Ref | 0.001 | Ref | 0.01 |
Yes | 168 (6%) | 138 (82%) | 30 (18%) | 0.59 (0.43, 0.81) | 0.63 (0.45, 0.90) | |||
Anterior chamber cells at baseline | Quiet | 1153 (43%) | 884 (77%) | 269 (23%) | Ref | <0.001 | Ref | <0.001 |
0.5+ | 530 (20%) | 369 (70%) | 161 (30%) | 1.46 (1.17, 1.83) | 1.48 (1.17, 1.87) | |||
1+ | 472 (18%) | 377 (80%) | 95 (20%) | 0.89 (0.68, 1.16) | 0.88 (0.66, 1.17) | |||
≥2+ | 526 (20%) | 421 (80%) | 105 (20%) | 0.79 (0.61, 1.02) | 0.87 (0.66, 1.15) | |||
Keratic precipitates | No | 2079 (83%) | 1580 (76%) | 499 (24%) | Ref | <0.001 | Ref | <0.001 |
Yes | 430 (17%) | 334 (78%) | 96 (22%) | 0.37 (0.22, 0.61) | 0.36 (0.21, 0.60) | |||
Synechia | Neither | 1940 (72%) | 1459 (75%) | 481 (25%) | Ref | <0.001 | Ref | 0.008 |
Peripheral Synechia Only | 61 (2%) | 43 (70%) | 18 (30%) | 0.74 (0.42, 1.29) | 0.69 (0.36, 1.32) | |||
Posterior Synechia Only | 604 (23%) | 488 (81%) | 116 (19%) | 0.67 (0.55, 0.83) | 0.72 (0.58, 0.90) | |||
Posterior and Peripheral Synechia | 79 (3%) | 66 (84%) | 13 (16%) | 0.56 (0.38, 0.84) | 0.62 (0.41, 0.93) | |||
Juvenile Idiopathic Arthritis | No | 2192 (78%) | 1602 (73%) | 590 (27%) | Ref | <0.001 | Ref | <0.001 |
Yes | 603 (22%) | 531 (88%) | 72 (12%) | 0.34 (0.25, 0.47) | 0.37 (0.26, 0.53) | |||
Spondyloarthropathy | No | 2525 (90%) | 1899 (75%) | 626 (25%) | Ref | <0.001 | Ref | <0.001 |
Yes | 270 (10%) | 234 (87%) | 36 (13%) | 0.41 (0.27, 0.62) | 0.35 (0.23, 0.54) | |||
Age at presentation | <40 | 1384 (50%) | 1106 (80%) | 278 (20%) | Ref | <0.001 | Ref | 0.03 |
40+ | 1411 (50%) | 1027 (73%) | 384 (27%) | 1.77 (1.46, 2.16) | 1.29 (1.02, 1.63) |
Includes pa4ents who did not return for follow-up after 90 days, but had 1 or more follow-up visits before 90 days and had remained inactive without receiving suppressive medications at all of those visits, as being in remission.
Adjusted for age at presentation, bilateral, duration of uveitis prior to presentation, prior cataract surgery, any glaucoma surgery, anterior chamber cells at baseline, keratic precipitates, synechia, juvenile idiopathic arthritis, spondyloarthropathy